Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA CIPLA DISHMAN PHARMA/
CIPLA
 
P/E (TTM) x 30.0 33.7 89.1% View Chart
P/BV x 3.3 4.3 78.3% View Chart
Dividend Yield % 0.7 0.5 146.3%  

Financials

 DISHMAN PHARMA   CIPLA
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
CIPLA
Mar-22
DISHMAN PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs3741,083 34.6%   
Low Rs129806 16.0%   
Sales per share (Unadj.) Rs197.0269.7 73.0%  
Earnings per share (Unadj.) Rs21.231.7 66.8%  
Cash flow per share (Unadj.) Rs34.744.8 77.5%  
Dividends per share (Unadj.) Rs2.005.00 40.0%  
Avg Dividend yield %0.80.5 150.2%  
Book value per share (Unadj.) Rs179.9257.8 69.8%  
Shares outstanding (eoy) m80.70806.81 10.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.5 36.5%   
Avg P/E ratio x11.929.8 39.9%  
P/CF ratio (eoy) x7.321.1 34.4%  
Price / Book Value ratio x1.43.7 38.2%  
Dividend payout %9.415.8 59.9%   
Avg Mkt Cap Rs m20,307762,177 2.7%   
No. of employees `000NANA-   
Total wages/salary Rs m5,35535,299 15.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,898217,633 7.3%  
Other income Rs m2653,217 8.2%   
Total revenues Rs m16,163220,851 7.3%   
Gross profit Rs m4,10343,298 9.5%  
Depreciation Rs m1,09110,520 10.4%   
Interest Rs m9441,064 88.8%   
Profit before tax Rs m2,33434,933 6.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6249,338 6.7%   
Profit after tax Rs m1,71025,595 6.7%  
Gross profit margin %25.819.9 129.7%  
Effective tax rate %26.726.7 100.0%   
Net profit margin %10.811.8 91.5%  
BALANCE SHEET DATA
Current assets Rs m11,018147,108 7.5%   
Current liabilities Rs m9,51749,129 19.4%   
Net working cap to sales %9.445.0 21.0%  
Current ratio x1.23.0 38.7%  
Inventory Days Days5763 90.7%  
Debtors Days Days36 60.9%  
Net fixed assets Rs m18,787119,415 15.7%   
Share capital Rs m1611,614 10.0%   
"Free" reserves Rs m14,354206,364 7.0%   
Net worth Rs m14,516207,977 7.0%   
Long term debt Rs m4,1894,162 100.6%   
Total assets Rs m29,805266,523 11.2%  
Interest coverage x3.533.8 10.3%   
Debt to equity ratio x0.30 1,442.1%  
Sales to assets ratio x0.50.8 65.3%   
Return on assets %8.910.0 89.0%  
Return on equity %11.812.3 95.7%  
Return on capital %17.517.0 103.3%  
Exports to sales %24.926.2 94.9%   
Imports to sales %3.78.2 45.7%   
Exports (fob) Rs m3,95657,094 6.9%   
Imports (cif) Rs m59417,803 3.3%   
Fx inflow Rs m4,95260,180 8.2%   
Fx outflow Rs m69717,803 3.9%   
Net fx Rs m4,25542,376 10.0%   
CASH FLOW
From Operations Rs m2,78633,259 8.4%  
From Investments Rs m-1,529-18,719 8.2%  
From Financial Activity Rs m-941-15,998 5.9%  
Net Cashflow Rs m317-1,323 -23.9%  

Share Holding

Indian Promoters % 61.4 13.5 455.2%  
Foreign collaborators % 0.0 20.1 -  
Indian inst/Mut Fund % 23.0 49.4 46.5%  
FIIs % 12.0 27.7 43.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 66.4 58.1%  
Shareholders   52,291 388,864 13.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Cipla Share Price Performance

Period Dishman Pharma Cipla S&P BSE HEALTHCARE
1-Day 2.87% -2.09% -0.47%
1-Month -2.45% -5.02% -2.35%
1-Year 96.38% 19.49% -5.96%
3-Year CAGR 50.28% 33.35% 20.82%
5-Year CAGR 41.17% 13.09% 11.39%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Cipla the stake stands at 33.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Cipla paid Rs 5.0, and its dividend payout ratio stood at 15.8%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.